CONTENT OF BIOACTIVE SUBSTANCES AND ELEMENTAL COMPOSITION OF SAINT JOHN’S WORT HERBS OF DIFFERENT PRODUCERS
DOI:
https://doi.org/10.11603/2312-0967.2018.4.9576Keywords:
Hypericum perforatum, herb, St. John's wort, elemental composition, hypericin, rutin, hyperoside, atomic absorption spectrometry, high-performance liquid chromatographyAbstract
The aim of the work is to determine the content of bioactive substances and elemental composition of St. John's wort herbs of different producers and reveal correlations between the contents of API and microelements.
Materials and Methods. The research used certified reference materials for organic substances produced by the company Fluka and for metal ions produced by O.V.Bogatsky Physicochemical Institute, and samples of herbs of St. John's wort of different producers.
Analytical equipment. Hewlett Packard 8452A spectrophotometer; Shimadzu LC-20 liquid chromatograph, equipped with UV detector and Phenomenex Luna C18 column; and Solaar S4 AA atomic absorption spectrophotometer (Thermo Electron Co., USA).
Statistical calculations were performed using the IBM SPSS-19 statistical software package.
Results and Discussion. The content of bioactive substances (hypericin, hyperoside, rutin, quercetin, and chlorogenic, neochlorogenic, rosemary and caffeic acids) and elemental composition have been investigated for samples of St. John's wort herb of four different producers. Significant variation in the content of organic compounds is registered. For example, the content of hypericin, one of the main active pharmaceutical ingredients of St. John's wort, varies 2-5 times. Statistically significant positive or negative correlations were found between the contents of certain elements (K, Mg, Fe, Mn, and Cd) and the content of organic substances (rutin, hyperoside, hypericin and hydroxycinnamic acids).
Conclusions. The content of biologically active substances, namely hypericin, rutin, hyperoside and studied hydroxycinnamic acids, varies considerably depending on the origin and elemental composition of St. John's wort herb samples.
References
Community herbal monograph on Hypericum perforatum L., herba (well-established medicinal use). London (UK): European Medicines Agency, 2009. Available from: https://www.ema.europa.eu/documents/herbal-monograph/final-community-herbal-monograph-hypericum-perforatum-l-herba-well-established-medicinal-use_en.pdf (Accessed November 2018).
Denys A, Ivanova А, Hroshovyi T. Porivnialni doslidzhennia asortymentu likarskykh zasobiv na osnovi roslynnoi syrovyny, predstavlenoho na farmatsevtychnykh rynkakh Ukrainy ta Polshchi [Comparative study of assortment of drugs based on herbal raw material represented at pharmaceutical market of Ukraine and Poland]. Farmacevt. chasop. 2016;3:26-31. Ukrainian. https://doi.org/10.11603/ 2312-0967.2016.3.6818.
Agapouda A, Booker A, Kiss T, Hohmann J, Heinrich M, Csupor D. Quality control of Hypericum perforatum L. analytical challenges and recent progress. J. Pharm. Pharmacol. 2017. Available from: https://onlinelibrary.wiley. com/doi/epdf/10.1111/jphp.12711.
Nahrstedt A, Butterweck V. Lessons learned from herbal medicinal products: the example of St. John's Wort. J. Nat. Prod. 2010;73(5):1015-21.
Barnes J, Anderson LA, Phillipson JD. St John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties. Review. J. Pharm. Pharmacol. 2001;53(5):583-600. https://doi.org/10.1211/ 0022357011775910.
Butterweck V. Schmidt M. St. John’s wort: Role of active compounds for its mechanism of action and efficacy. Wien Med. Wochenschr. 2007;157(13-14):356-61. DOI 10.1007/s10354-007-0440-8.
Ukrainian Scientific Pharmacopoeial Center for Quality of Medicines. State Pharmacopoeia of Ukraine [Державна Фармакопея України]. 2nd ed., Vol. 3. Kharkiv: Ukrainian Scientific Pharmacopoeial Center for Quality of Medicines; 2015, 327-30.Ukrainian.
Hudzenko AV. Doslidzhennia rechovyn-markeriv dlia rozrobky metodyk kontroliu yakosti likarskykh roslyn, yikh sumishei ta polikomponentnykh fitopreparativ [Investigation of marker substances for the development of methods for quality control of medicinal plants, their mixtures and polycomponent phytopreparations]. Kyiv: DU «Instytut farmakolohii ta toksykolohii NAMN Ukrainy»; 2014. Ukrainian.
Ukrainian Scientific Pharmacopoeial Center for Quality of Medicines. State Pharmacopoeia of Ukraine [Державна Фармакопея України]. 2nd ed., Vol. 1. Kharkiv: Ukrainian Scientific Pharmacopoeial Center for Quality of Medicines; 2015, 86-8.Ukrainian.
Ukrainian Scientific Pharmacopoeial Center for Quality of Medicines. State Pharmacopoeia of Ukraine [Державна Фармакопея України]. 2nd ed., Vol. 1. Kharkiv: Ukrainian Scientific Pharmacopoeial Center for Quality of Medicines; 2015, 131-2. Ukrainian.
Derkach TM, Khomenko VG. [Essential and Toxic Microelements in the Medicinal Remedy Hyperichi herba by Different Producers]. Res. J. Pharm. Technol. 2018;11(2):466-474. DOI: 10.5958/0974-360X.2018.00086.0
Derkach T, Khomenko V. Elemental Composition of the Medicinal Plants Hypericum perforatum, Urtica dioica and Matricaria chamomilla Grown in Ukraine: A Comparative Study. Pharmacognosy J. 2018;10(3):486-491. DOI: 10.5530/pj. 2018.3.80
Baula OP, Derkach TM. Suchasni pidkhody do kontroliu elementnykh domishok u likarskykh zasobakh roslynnoho pokhodzhennia [Modern approaches to the control of elemental impurities in medicinal herbs]. Farmatsevt. Zhurn. 2017;3-4:43-53. Ukrainian.
Kabata-Pendias A. Trace Elements in Soils and Plants, fourth ed., CRC Press, Boca Raton, Fl, USA. 2011.
Owen JD. Investigation of the Elemental Profiles of Hypericum perforatum as used in herbal remedies. University of Hertfordshire, UK, 2013. Available from: https://core.ac.uk/download/pdf/29840202.pdf
Guideline ST-NMOZU 42-4.5:2012 Medicinal products. Good growth and collection practice for herbal starting materials. [Настанова СТ-Н МОЗУ 42-4.5:2012. Лікарські засоби. Належна практика культивування та збирання вихідної сировини рослинного походження]. Kyiv: Ministry of Health of Ukraine; 2012. Ukrainian.
Guideline ST-NMOZU 42-4.0:2016 Medicinal products. Good manufacturing practice. [Настанова СТ-Н МОЗУ 42-4.0:2016 Лікарські засоби. Належна виробнича практика]. Kyiv: Ministry of Health of Ukraine; 2016. Ukrainian.
Guideline ST-NMOZU 42-5.1:2011 Medicinal products. Good storage practice. [Настанова СТ-Н МОЗУ 42-5.1:2011 Лікарські засоби. Належна практика зберігання]. Kyiv: Ministry of Health of Ukraine; 2011. Ukrainian.
Guideline ST-NMOZU 42-5.0:2014 Medicinal products. Good distribution practice. [Настанова СТ-Н МОЗУ 42-5.0:2014 Лікарські засоби. Належна практика дистрибуції]. Kyiv: Ministry of Health of Ukraine; 2014. Ukrainian.
Ukrainian Scientific Pharmacopoeial Center for Quality of Medicines. State Pharmacopoeia of Ukraine [Державна Фармакопея України]. 2nd ed., Suppl. 3. – Kharkiv: Ukrainian Scientific Pharmacopoeial Center for Quality of Medicines; 2018, 45-8.Ukrainian.
Baula OP, Derkach TM. Zabezpechennia yakosti likarskykh zasobiv roslynnoho pokhodzhennia: stan ta perspektyvy [Quality assurance of herbal medicinal products: status and prospects]. Farmacevt. chasop. 2017;2:79-86. Ukrainian. DOI 10.11603/2312-0967.2017.2.7816
Downloads
Published
Issue
Section
License
The authors who publish their materials in this journal agree with the following terms:
- Authors reserve the right to authorship of their work and assign to the journal the right to first publish this work under the terms of the Creative Commons Attribution License, which allows other persons to freely distribute the published work with a mandatory reference to the authors of original work and the first publication of work in this journal
. - Authors have the right to make independent extra-exclusive work agreements in the form they are published by this journal (for example, posting work in an electronic repository of an institution or publishing as part of a monograph), provided that the link to the first publication of the work in this journal is maintained.
Journal policy allows and encourages publication of manuscripts on the Internet (for example, in institutions repositories or on personal websites), both before the publication of this manuscript and during its editorial review, as it contributes to productive scientific discussion and positively affects the efficiency and dynamics of the citation of the published work (see The Effect of Open Access).